Taiwan Scientists Develop New Hair Regrowth Serum That Shows Results in Just 20 Days

Scientists at National Taiwan University (NTU) studied hair growth on mice in 20 days using a natural fatty acid serum with no chemicals, no irritation, and no surgery. The study, published in Cell Metabolism in October 2025, links fat cells, immune cells, and sleeping hair follicles in a way researchers have never demonstrated before. For the 50 million Americans affected by hair loss, this is the most important hair science published in years.

This article explains the exact biological mechanism, compares this serum directly against Minoxidil and hair transplants, identifies the 3 biggest challenges for human use, and answers the 10 questions people are searching right now.

What Is the National Taiwan University Hair Growth Serum?

The NTU serum is a topical solution containing monounsaturated fatty acids (MUFAs) specifically oleic acid (C18:1) and palmitoleic acid (C16:1) dissolved in alcohol. Both compounds already exist in human fat tissue and common plant oils such as olive oil and sea buckthorn. Professor Sung-Jan Lin led the research team at NTU’s Department of Dermatology.

The core finding: when these fatty acids are applied directly to the skin, they activate dormant hair-follicle stem cells (HFSCs) and push them into the growth (anagen) phase. The serum produced visible new hair in mouse models within 20 days.

The study title is: “Adipocyte lipolysis activates epithelial stem cells for hair regeneration through fatty acid metabolic signalling.” First author Kang-Yu Tai worked alongside Professor Lin.

The Science: 4 Steps from Fat Cell to New Hair

Most competitors covering this story describe the serum in vague terms. Here is exactly how it works, step by step:

1. Skin irritation triggers immune response. When skin is mildly inflamed or injured, macrophages (white blood cells) move into the dermal adipose (fat) layer.
2. Macrophages trigger fat breakdown. The macrophages initiate a process called SAA3-dependent lipolysis, breaking down fat cells and releasing free fatty acids.
3. Fatty acids fuel stem cells. HFSCs absorb the fatty acids. The fatty acids stimulate mitochondrial biogenesis the stem cells generate more mitochondria, boosting their energy supply.
4. Stem cells switch to growth mode. The energized HFSCs exit their resting (telogen) state and enter the anagen (growth) phase, producing new hair.

The NTU serum bypasses steps 1 and 2 entirely. It delivers the fatty acids directly to the skin surface, tricking HFSCs into believing a healing signal has arrived without any actual irritation.

Professor Lin Tested It on Himself

Before animal trials were complete, Professor Lin applied oleic acid and palmitoleic acid, dissolved in alcohol, to his own thighs for 3 weeks. He confirmed hair regrowth in that area. This is a rare example of a principal investigator self-testing a formula, and it added credibility to the early data.

Animal trials then confirmed the same result at scale. Shaved mice treated with the serum showed new, thicker hair within 20 days. Microscopic examination showed stronger, more active hair roots than untreated controls.

The Eczema Experiment: Where the Idea Came From

The NTU team first applied sodium dodecyl sulfate (SDS) a common shampoo foaming ingredient to shaved mice. SDS caused eczema-like inflammation. New hair grew in those inflamed areas within 10 days. That was the signal.

Instead of using SDS, the team asked: what does inflammation release that actually triggers the hair growth? The answer was monounsaturated fatty acids. They removed the irritant and kept only the active signal. That is the serum.

NTU Serum vs. Minoxidil vs. Hair Transplant: Direct Comparison

This is where competitor articles are weakest. They list current treatments but never compare them directly with the NTU research. Here is an honest comparison:

Minoxidil (Rogaine): FDA-approved, extends growth phase via vasodilation. Works in ~40% of users. Side effects include scalp irritation, initial shedding, and rare systemic effects. Requires daily use indefinitely stopping reverses gains.

Finasteride (Propecia): FDA-approved for men only. Blocks DHT. Side effects include sexual dysfunction in 2–4% of users. Not for women of childbearing age. Daily oral pill.

Hair Transplant (FUE): Surgical. Permanent in most cases. Cost: $4,000–$15,000+ USD. Requires donor hair. Not suitable for diffuse thinning or advanced baldness.

NTU Fatty Acid Serum: Pre-clinical (mouse models). Natural MUFAs. No known side effects at this stage. Activates follicle stem cells directly. Not yet in human trials. Patent filed.

The NTU serum targets a fundamentally different mechanism than Minoxidil. Minoxidil works on blood flow. The NTU serum works on stem cell energy metabolism. These could eventually be complementary, not competing, treatments.

3 Real Challenges Before This Reaches U.S. Pharmacies

Most articles about this discovery skip the obstacles. These 3 challenges are the honest reality:

1. Human skin is thicker than mouse skin. Dr. Luis Garza, a dermatologist at Johns Hopkins University, told Newsweek: the biggest challenge is ensuring the serum penetrates deep enough to reach follicles in the human scalp. Hair follicles sit 3–4 mm deep in human skin. Absorption formulations for the scalp require significant reformulation from mouse experiments.
2. Human hair loss is hormone-driven. Androgenetic alopecia (pattern baldness) in humans is largely driven by dihydrotestosterone (DHT) sensitivity in follicles. Mouse models do not replicate this hormonal component. Human trials must confirm whether fatty acid signaling can override or bypass DHT’s miniaturization effect on follicles.
3. Regulatory path takes 5–10 years. Even with successful Phase 1, 2, and 3 clinical trials, FDA approval for a new hair loss treatment takes roughly 5–10 years from first human application. The NTU team has not yet entered Phase 1.

Who Is Most Likely to Benefit?

If human trials succeed, researchers believe this serum will be most effective for:

• People in early-stage hair thinning where follicles are dormant but not fully dead
• Patients who cannot use Minoxidil or Finasteride due to side effects
• Women with diffuse hair loss (no FDA-approved topical option with this mechanism)
• Post-surgical or post-chemotherapy patients experiencing temporary follicle dormancy
• People with alopecia areata, where immune activity has shut down follicle cycling

According to the World Population Review, 42% of men in the United States experience significant hair loss. Globally, the number exceeds 1.2 billion people. The NTU research addresses the root cause of follicle dormancy, not just cosmetic coverage.

Where Is the NTU Serum Now?

As of early 2026, the NTU team has:

• Filed a patent on the formula
• Confirmed positive results when applied to human hair follicle cells in laboratory settings
• Stated the next goal is identifying the right formulation, concentration, and dosage for human scalp application
• Not yet entered Phase 1 human clinical trials

Professor Lin stated: “Our next goal is to identify the right formulation that can safely stimulate human hair growth. If successful, it could become an affordable over-the-counter product for everyone.”

The phrase “over-the-counter” is significant. Both Minoxidil and this serum use naturally occurring compounds. FDA OTC approval is a realistic long-term scenario if human safety data is clean.

Why This Discovery Matters Beyond Hair Loss

The NTU research establishes a new principle: fat cells communicate directly with tissue stem cells to trigger regeneration. This is not limited to hair. The same macrophage-adipocyte-stem cell signaling axis may apply to:

• Wound healing and skin regeneration
• Nail growth disorders
• Recovery from burns or radiation therapy
• Broader regenerative medicine applications

This is why Cell Metabolism one of the most selective journals in metabolic biology published the study. The hair regrowth result is the application. The discovery is a new communication pathway between two cell types no one had linked before.

Related Reading

For more science and technology breakthroughs, read:

• Scientists Created a Gel That Triggers Hair Growth and May Cure Baldness Naturally MyElectricSparks
• How Does Artificial Intelligence Actually Work? MyElectricSparks
• Neuralink Brain Chip Lets Paralyzed Veteran Play Games With Mind MyElectricSparks

External source: Cell Metabolism Original Study (PubMed)

Frequently Asked Questions

1. What is the National Taiwan University hair growth serum made of?

The serum contains oleic acid (C18:1) and palmitoleic acid (C16:1) monounsaturated fatty acids dissolved in alcohol. Both occur naturally in human fat tissue and plant oils like olive oil. No synthetic chemicals are used in the active formula.

2. How fast did hair grow in the NTU study?

Hair grew within 20 days in mouse models treated with the fatty acid serum. In the eczema-irritant experiment using SDS, hair appeared in as few as 10 days. These are mouse results human timelines are unknown until clinical trials complete.

3. Is the NTU hair growth serum available to buy?

No. The serum is not available for purchase. The NTU team has patented the formula and is preparing for human clinical trials. It has not received FDA approval and has not entered Phase 1 trials as of early 2026.

4. How does the NTU serum differ from Minoxidil?

Minoxidil works by widening blood vessels to increase scalp blood flow and extend the hair growth phase. The NTU serum works by delivering fatty acids that activate hair follicle stem cells through mitochondrial energy signaling. These are fundamentally different biological mechanisms one targets circulation, the other targets stem cell metabolism.

5. Did the NTU scientist test the serum on himself?

Yes. Professor Sung-Jan Lin applied the fatty acid formula to his own thighs for 3 weeks and confirmed hair regrowth. This was an informal self-experiment prior to formal animal trials, not a clinical study.

6. What type of hair loss can this serum treat?

Based on mouse results, the serum reactivates dormant (resting phase) hair follicles. It is most likely to help people with follicles that are dormant but not permanently damaged this includes early-stage androgenetic alopecia, alopecia areata, stress-related hair loss (telogen effluvium), and post-chemotherapy hair loss. People with fully destroyed follicle roots may not benefit.

7. Why did the NTU researchers use eczema to study hair growth?

The team observed that eczema-like skin inflammation caused by SDS triggered new hair growth in mice. That observation led them to investigate what the inflammation was releasing that stimulated follicles. The answer was monounsaturated fatty acids from fat cells. The serum recreates that signal without the irritation.

8. When will NTU hair growth serum human trials start?

No official start date for human clinical trials has been announced. Professor Lin confirmed the team’s next step is finalizing the formulation for human scalp use. Realistically, Phase 1 safety trials could begin within 2–4 years, with a full FDA approval pathway taking 7–10 years from that point.

9. Is the NTU serum safe?

In mouse models, no significant side effects were observed. Oleic acid and palmitoleic acid are already present in the human body and in common foods. The NTU team does not anticipate serious side effects. However, safety in humans must be confirmed through formal clinical trials no human safety data exists yet.

10. What does the NTU hair study mean for the future of hair loss treatment?

The NTU discovery establishes a new signaling pathway: fat cells release fatty acids that directly activate hair follicle stem cells. This mechanism is different from every existing approved hair loss treatment. If human trials succeed, this could become a natural, affordable, over-the-counter product that treats hair loss at the stem cell level not just the surface.